Women with primary ovarian insufficiency have lower bone mineral density
AUTOR(ES)
Amarante, F., Vilodre, L.C., Maturana, M.A., Spritzer, P.M.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
2011-01
RESUMO
The aim of the present study was to assess the prevalence of osteoporosis in a sample of 32 patients with spontaneous primary ovarian insufficiency (POI) in comparison to reference groups of 25 pre- and 55 postmenopausal women. Hip (lumbar) and spinal bone mineral density (BMD) measurements were performed by dual-energy X-ray absorptiometry in the three groups. The median age of POI patients at the time of diagnosis was 35 years (interquartile range: 27-37 years). The mean ± SD age of postmenopausal reference women (52.16 ± 3.65 years) was higher than that of POI (46.28 ± 10.38 years) and premenopausal women (43.96 ± 7.08; P = 0.001) at the time of BMD measurement. Twenty-seven (84.4%) POI women were receiving hormone replacement therapy (HRT) at the time of the study. In the postmenopausal reference group, 30.4% were current users of HRT. Lumbar BMD was significantly lower in the POI group (1.050 ± 0.17 g/cm²) compared to the age-matched premenopausal reference group (1.136 ± 0.12 g/cm²; P = 0.040). Moreover, 22 (68.7%) POI women had low bone density (osteopenia/osteoporosis by World Health Organization criteria) versus 47.3% of the postmenopausal reference group (P = 0.042). In conclusion, the present data indicate that BMD is significantly lower in patients with POI than in age-matched premenopausal women. Also, the prevalence of osteopenia/osteoporosis is higher in POI women than in women after natural menopause. Early medical interventions are necessary to ensure that women with POI will maintain their bonemass.
Documentos Relacionados
- Cut off values of bone mineral density defining postmenopausal women with bone fractures.
- Bone Mineral Density in Estrogen-Deficient Young Women
- Loss of bone mineral density in premenopausal women with systemic lupus erythematosus.
- Ghrelin plasma levels, gastric ghrelin cell density and bone mineral density in women with rheumatoid arthritis
- Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.